Epilepsia Vol. 42, 2001 Author Index
- 卷第42卷
- 期第12期
- 印刷ISSN1528-1167
- 文件大小83.49KB
- 发表时间2001
- DOI10.1046/j.1528-1157.2001.ai4212.x
- 页码1628-1633
Long-Term Treatment Retention with TopiramateC. L. P. Deckers; W. O. Renier · 2001
Diffusion of the new antiepileptic drug lamotrigine in Dutch clinical practiceP. D. Knoester; S. V. Belitser; C. L. P. Deckers; A. Keyser; W. O. Renier; A. C. G. Egberts; Y. A. Hekster · 2004
Pharmacotherapy of epilepsy: state of the art and developmentsC. L. P. Deckers; Y. A. Hekster; A. Keyser; H. Meinardi; W. O. Renier · 1997
Adverse effects in epilepsy therapy. Wait and see or go for it?C. L. P. Deckers; Y A. Hekster; A. Keyser; M. W. Lammers; H. Meinardi; W. O. Renier · 1997
Reappraisal of Polytherapy in Epilepsy: A Critical Review of Drug Load and Adverse EffectsC. L. P. Deckers; Y. A. Hekster; A. Keyser; H. Meinardi; W. O. Renier · 1997
Patterns of lamotrigine use in daily clinical practice during the first 5 years after introduction in the NetherlandsP. D. Knoester; S. V. Belitser; C. L. P. Deckers; A. Keyser; W. O. Renier; A. C. G. Egberts; Y. A. Hekster · 2004
A Cost-Effectiveness Decision Model for Antiepileptic Drug Treatment in Newly Diagnosed Epilepsy PatientsPieter D. Knoester; Charles L. P. Deckers; Eveline H. Termeer; Arjo J. Boendermaker; Irene A. W. Kotsopoulos; Marc C. T. F. M. De Krom; Toine Keyser; Willy O. Renier; Yechiel A. Hekster; Hans L. Severens · 2007